Latest Kaiser Health News Stories
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Genetic testing firms declare bankruptcy and wipe out debt to the federal government.
Medicare and insurers struggle to oversee a booming business in testing urine samples. In some cases, pain doctors’ lack of follow-through can turn fatal.
With the nation’s opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned “the lion’s share” of their Medicare income exclusively from urine drug screens.